The Selphyl® System is designed for the safe and rapid preparation of Platelet-rich Fibrin Matrix (PRFM) from a small sample of blood at the patient point of care. Many PRP systems require operator skill, have varying results and have extensive contamination with red blood cells and white blood cells. Selphyl® removes virtually all contaminating cells and is independent of operator technique. PRP is converted to PRFM through a controlled process, creating a scaffold that serves to protect and preserve platelets. Think of Selphyl® PRFM as the next generation PRP.
Platelets and other components in human blood migrate to a site of injury. Platelets are known to release a variety of growth factors that respond to tissue injury, where they initiate and promote healing. By concentrating platelets at the site of injury, physicians have the potential to enhance the body’s natural capacity for healing.
| Benefits |
|
|---|---|
| FAQs | WHAT IS PLATELET-RICH PLASMA (PRP)? WHAT IS SELPHYL® PRFM? HOW IS SELPHYL® PLATELET-RICH FIBRIN MATRIX (PRFM) DIFFERENT? HOW LONG DOES THE PROCEDURE TAKE? HOW MANY TREATMENTS ARE NEEDED? IS THE TREATMENT PAINFUL? ARE THERE ANY SIDE EFFECTS? CAN ANYONE BE ALLERGIC TO SELPHYL®? |
| Treatment Type | Injectables, PRP Procedures |
| Treatment Problem or Condition | Fine Lines, Hair Loss, Sagging/Loose Skin, Wrinkles |
| Brand | Selphyl |
THE SELPHYL® PROCESS
- During a short office visit (30 minutes), a small amount of a patient’s own blood is drawn into a vacuum collection tube containing a cell separator gel.
- The tube is then placed into a centrifuge and spun for six minutes to separate the blood into a supernatant plasma/platelet suspension.
- The red and white blood cells are located below the cell separator gel.
- The platelets and plasma are then transferred in a closed system to a second vacuum tube containing a small amount of calcium chloride solution.
- Fibrin polymerization begins and the PRP remains liquid for approximately 10 minutes before forming PRFM.
- The patient’s own PRFM is ready for use as deemed appropriate by the clinical use requirements.

